Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Robert A. Anders"'
Autor:
Alan E. Berger, Alan K. Meeker, Tracee L. McMiller, Robert A. Anders, Shuming Chen, Aleksandra Ogurtsova, Suzanne L. Topalian, Maria Libera Ascierto, Richard F. Ambinder, Janis M. Taube, Neil A. Phillips, Amy S. Duffield, Haiying Xu, Drew M. Pardoll
Classical Hodgkin lymphoma (CHL) is a neoplasm characterized by robust inflammatory infiltrates and heightened expression of the immunosuppressive PD-1/PD-L1 pathway. Although anti-PD-1 therapy can be effective in >60% of patients with refractory CHL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc4ffb0cd6533b6dcecd996dedf09c47
https://europepmc.org/articles/PMC5727974/
https://europepmc.org/articles/PMC5727974/
Autor:
Sudarshan Anand, Andrew S. Flies, Yanhui Xu, Koji Tamada, Haiying Xu, Gefeng Zhu, Dallas B. Flies, Robert A. Anders, Lieping Chen, Sarah J. Flies, Wayne W. Hancock
Publikováno v:
Blood. 109:4097-4104
Decoy lymphotoxin β receptor (LTβR) has potent immune inhibitory activities and thus represents a promising biologic for the treatment of inflammation, autoimmune diseases, and graft-versus-host disease (GVHD). As this reagent interrupts multiple m
Publikováno v:
Blood. 118:1052-1052
Abstract 1052 Background: Chronic red cell transfusions are commonly used for the treatment and prevention of complications in sickle cell disease (SCD). Liver injury from transfusional iron overload is a recognized morbidity of chronic transfusion t